Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1/24/24 18:44 | 1/22/24 | VRDN | Health | Health | Medical Laboratories | Fairmount Funds Management LLC | PA | DTH | See Rema | P | 10,000 | 21.00 | 0 | 476 | 35 | 1,846 | I | ||||||||||||||
4/12/23 19:05 | 4/12/23 | VRDN | Health | Health | Medical Laboratories | Myers Scott Dunseth | MA | DO | CEO | P | 101 | 25.37 | 0 | 4 | 2 | 260 | D | ||||||||||||||
3/13/23 16:06 | 3/13/23 | VRDN | Health | Health | Medical Laboratories | Myers Scott Dunseth | MA | DO | CEO | P | 160 | 29.15 | 0 | 6 | 2 | 256 | D | ||||||||||||||
8/19/22 16:32 | 8/17/22 | VRDN | Health | Health | Medical Laboratories | Fairmount Funds Management LLC | PA | DTH | See Rema | P | 10,000 | 23.50 | 0 | 426 | 45 | 1,370 | I | ||||||||||||||
9/28/21 19:46 | 9/23/21 | VRDN | Health | Health | Medical Laboratories | Frazier Life Sciences Public Fund, L.P. | WA | T | P | 2,200 | 11.00 | 0 | 200 | 15 | 1,505 | D | |||||||||||||||
9/23/21 09:30 | 9/21/21 | VRDN | Health | Health | Medical Laboratories | Fairmount Funds Management LLC | PA | DT | P.d | 9,999 | 11.00 | 0 | 909 | 999% | 944 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |